Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aalamroots is a biotechnology company focused on cellular rejuvenation and the reversal of biological aging. The company leverages partial cellular reprogramming technologies to reset the epigenetic state of cells, aiming to restore youthful function and treat age-related pathologies. By utilizing a combination of computational modeling and high-throughput biological screening, Aalamroots identifies optimal combinations of factors to induce rejuvenation safely. Their mission is to extend human healthspan by targeting the underlying mechanisms of cellular senescence and epigenetic drift.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aalamroots.